Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells

Wnt1-inducible signaling pathway protein-1 is a cysteine-rich protein that belongs to the CCN family, which has been implicated in mediating the occurrence and progression through distinct molecular mechanisms in several tumor types. However, the association of Wnt1-inducible signaling pathway protein-1 with gastric cancer and the related molecular mechanisms remain to be elucidated. Therefore, this study aimed to clarify the biological role of Wnt1-inducible signaling pathway protein-1 in the proliferation, migration, and invasion in gastric cancer cells and further investigated the associated molecular mechanism on these biological functions. We first detected the expression level of Wnt1-inducible signaling pathway protein-1 in gastric cancer, and the reverse transcription polymerase chain reaction have shown that Wnt1-inducible signaling pathway protein-1 expression levels were upregulated in gastric cancer tissues. The expression of Wnt1-inducible signaling pathway protein-1 in gastric cancer cell lines was also detected by quantitative real-time polymerase chain reaction and Western blotting. Furthermore, two gastric cancer cell lines with high expression of Wnt1-inducible signaling pathway protein-1 were selected to explore the biological function of Wnt1-inducible signaling pathway protein-1 in gastric cancer. Function assays indicated that knockdown of Wnt1-inducible signaling pathway protein-1 suppressed cell proliferation, migration, and invasion in BGC-823 and AGS gastric cancer cells. Further investigation of mechanisms suggested that cyclinD1 was identified as one of Wnt1-inducible signaling pathway protein-1 related genes to accelerate proliferation in gastric cancer cells. In addition, one pathway of Wnt1-inducible signaling pathway protein-1 induced migration and invasion was mainly through the enhancement of epithelial-to-mesenchymal transition progression. Taken together, our findings presented the first evidence that Wnt1-inducible signaling pathway protein-1 was upregulated in gastric cancer and acted as an oncogene by promoting proliferation, migration, and invasion in gastric cancer cells.

[1]  W. Jiang,et al.  Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression , 2016, Oncology Report.

[2]  H. Baarsma,et al.  WISP1 mediates IL-6-dependent proliferation in primary human lung fibroblasts , 2016, Scientific Reports.

[3]  Yinglan Jin,et al.  Knockdown of WISP1 inhibit proliferation and induce apoptosis in ALL Jurkat cells. , 2015, International journal of clinical and experimental pathology.

[4]  W. Jiang,et al.  WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways , 2015, British Journal of Cancer.

[5]  Y. Jan,et al.  WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer , 2015, Scientific Reports.

[6]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[7]  湯智昕,et al.  WISP-1 a novel angiogenic regulator of the CCN family promotes oral squamous cell carcinoma angiogenesis through VEGF-A expression , 2015 .

[8]  M. Bertagnolli,et al.  Comparison of Gastric Cancer Survival Between Caucasian and Asian Patients Treated in the United States: Results from the Surveillance Epidemiology and End Results (SEER) Database , 2015, Annals of Surgical Oncology.

[9]  Jason L Johnson,et al.  Wnt5a-Induced Wnt1-Inducible Secreted Protein-1 Suppresses Vascular Smooth Muscle Cell Apoptosis Induced by Oxidative Stress , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[10]  K. Maiese.  WISP1: Clinical insights for a proliferative and restorative member of the CCN family. , 2014, Current neurovascular research.

[11]  Chih-Hsin Tang,et al.  Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma. , 2013, Cellular signalling.

[12]  J. Chuang,et al.  Apoptosis Signal-Regulating Kinase 1 Is Involved in WISP-1–Promoted Cell Motility in Human Oral Squamous Cell Carcinoma Cells , 2013, PloS one.

[13]  J. Grichnik,et al.  Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1 , 2011, Oncogene.

[14]  Zhongqiu Lin,et al.  Expression and prognostic value of WISP‐1 in patients with endometrial endometrioid adenocarcinoma , 2011, The journal of obstetrics and gynaecology research.

[15]  S. Ishikawa,et al.  Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma. , 2011, Anticancer research.

[16]  J. Thiery,et al.  La transition épithéliomésenchymateuse au cours du développement dans la fibrose et dans la progression tumorale , 2010 .

[17]  K. Chua,et al.  [Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma]. , 2010, Bulletin du cancer.

[18]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[19]  Bin Zhou,et al.  Overexpression of connective tissue growth factor WISP-1 in Chinese primary rectal cancer patients. , 2007, World journal of gastroenterology.

[20]  T. Khor,et al.  A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma , 2006, International Journal of Colorectal Disease.

[21]  S. Thorgeirsson,et al.  Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer. , 2005, Journal of hepatology.

[22]  D. Brigstock.  The CCN family: a new stimulus package. , 2003, The Journal of endocrinology.

[23]  A. Levine,et al.  Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation* , 2003, The Journal of Biological Chemistry.

[24]  A. Levine,et al.  WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase. , 2002, Genes & development.

[25]  A. Levine,et al.  WISP-1 is a Wnt-1- and β-catenin-responsive oncogene , 2000, Genes & Development.

[26]  A. Levine,et al.  WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene. , 2000, Genes & development.